Literature DB >> 540104

Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.

T E Sadler, P D Jones, J E Castro, I A Lampert.   

Abstract

A strain of C. parvum, CN6134, known to have antitumour activity, caused thrombosis in the sites where the organism is phagocytosed. It bound to macrophages in vitro and activated the alternate pathway of complement. A strain of C. parvum, CN5888, which fails to show antitumour activity, did not show thrombosis. It did not bind to macrophages or activate guinea-pig complement. It did, however, cause marrow infarction which seems to result from a diminished clearance of the organism from the circulation.

Entities:  

Mesh:

Year:  1979        PMID: 540104      PMCID: PMC2041560     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  Prostaglandin synthesis in spleen cell cultures of mice injected with Corynebacterium parvum.

Authors:  W Grimm; M Seitz; H Kirchner; D Gemsa
Journal:  Cell Immunol       Date:  1978-10       Impact factor: 4.868

2.  A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system.

Authors:  W H McBride; J Dawes; N Dunbar; A Ghaffar; M F Woodruff
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

3.  The distribution and persistence in vivo of Corynebacterium parvum in relation to its antitumor activity.

Authors:  M T Scott; L Milas
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

4.  The characteristics of binding of Corynebacterium parvum to glass-adherent mouse peritoneal exudate cells.

Authors:  H M Ogmundsdóttir; D M Weir
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

Review 5.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

6.  Infarction of bone marrow in the sickle cell disorders.

Authors:  S Charache; D L Page
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

7.  Activation of the classical and alternate pathways of complement by Corynebacterium parvum.

Authors:  W H McBride; D M Weir; A B Kay; D Pearce; J R Caldwell
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

8.  Intravascular coagulation resulting from intravenous injection of C. parvum in mice.

Authors:  I A Lampert; P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

9.  Radiolabelling of Corynebacterium parvum and its distribution in mice.

Authors:  T E Sadler; W A Cramp; J E Castro
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

10.  Effect of Corynebacterium parvum on peripheral blood platelets.

Authors:  P D Jones; T E Sadler; J E Castro
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.